• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 2008T
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Death (1802); Loss of consciousness (2418)
Event Date 04/13/2017
Event Type  Death  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.Clinical investigation: the patient medical records were provided by the user facility.A clinical investigation was performed to identify a causal relationship between the hemodialysis (hd) treatment and the adverse event.Based on the provided medical records, a temporal association between the patient becoming unresponsive, requiring resuscitation measures, expiration, and the 2008t machine and other fresenius products exists.However, there is no documentation provided to indicate a causal relationship with the adverse events of the patient becoming unresponsive, requiring resuscitation measures, expiration, and the 2008t machine and other fresenius products.It is likely that the patient¿s recent myriad of medical issues and complex comorbid conditions (fractured and surgically repaired hip, worsening anasarca, hypoxemia, and dyspnea) put the patient at risk of sudden death.Additionally, there is no allegation against any fresenius products.No malfunction was reported.The dialysis machine was evaluated by the biomed and no repairs were needed as there was no indication of a malfunction or defect.
 
Event Description
A clinic manager at a user facility reported that during a hemodialysis (hd) treatment on (b)(6) 2017, approximately 7 minutes after the initiation of treatment, the patient lost consciousness and became unresponsive.Cardiopulmonary resuscitation (cpr) efforts were initiated and the facility called emergency medical services (ems).Ems personnel transferred the patient to emergency care at a medical center, who later notified the facility of the patient¿s death.Follow-up information revealed that the patient had initially been admitted to the hospital on (b)(6) 2017 for aggressive wound treatment of the left foot and had been prepped for hd therapy for aggressive volume removal and uremic toxin removal.Prior to the hospitalization, the patient had been at a rehabilitation center for almost a month following a right hip fracture with surgical repair.However, the patient had worsening anasarca, hypoxemia, dyspnea on exertion requiring supplemental oxygen, and weakness leading to the hospitalization of (b)(6) 2017.During the hospitalization, the patient had weakness, fatigue, shortness of breath, dyspnea on exertion, orthopnea, foamy urine, 4+ edema (left greater then right), weeping on dorsum of right foot and open sores, left foot cellulitis, hiccoughs and myoclonic jerking, and uremic symptoms.On (b)(6) 2017, a right internal jugular central venous catheter (cvc) was placed for hd therapy.The patient was discharged from the hospital on (b)(6) 2017.On (b)(6) 2017 at 10:40 am, the patient arrived at the user facility for the first hd treatment.The pre-treatment evaluation was as follows: cardiac rhythm: regular, normal rate, respiratory: lungs clear bilaterally, the patient was described as pleasant, using a wheel chair to ambulate, with non-symptoms of fluid overload, +1 to 2 mm or less bilaterally of lower leg, ankle and foot edema that disappears rapidly, wound dressing to left foot intact; vital signs: blood pressure (b/p) 135/45, pulse 60 regular, respiratory rate 16 afebrile, temperature 97.5°f, pre-weight (b)(6) kg.At the start of the hd treatment at 11:23 am, the patient¿s b/p was 141/58, pulse rate was 60 beats per minute (bpm), and 250ml normal saline (nacl) was administered.Seven minutes later, the nurse attempted to obtain the patient¿s oxygen (o2) saturation but the patient was pulling off the nasal cannula.The patient suddenly lost consciousness and became unresponsive.The patient was placed in trendelenburg, cpr was initiated, the patient¿s blood was returned, and ems was called.Automated external defibrillator (aed) pads were applied to the patient and analyzed with no shock advised.Cpr resumed using an ambu bag.At 11:40 am, ems personnel arrived with cpr still in progress.Aed analyzed a second time with no shock advised.Emergency medications (unknown type and dose) were given per ems protocol through the patient¿s cvc.The patient was intubated by ems and was transferred to the care of ems.The medical center notified the facility of the patient expiration on (b)(6) 2017.The cause of death was reported as cardiac arrest.It was reported that the 2008t hd machine in use at the time of the treatment did not alarm or provide any errors prior to treatment or at the time of the incident.The 2008t hd machine was removed from service following the event for an evaluation by the facility¿s on-site biomedical technician (biomed).The biomed verified machine operations and did not make any repairs.The machine was returned to service at the user facility without issue.No malfunction of any fresenius product in use during the hd treatment was alleged, observed, or identified prior to, during, or following the event.The dialyzer is not available for evaluation by the manufacturer as it was discarded by the user facility.No samples of the acid/bicarb in use during the treatment are available for analysis.
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.Additionally, no on-site evaluation of the unit was performed by a fresenius regional equipment specialist (res).The unit was pulled from service for evaluation by the facility biomedical engineer (biomed) following the event.The machine did not require any repairs and was confirmed to be operating properly.The unit has been returned to service at the user facility without a recurrence of the event as reported.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances or any associated rework during the manufacturing process which could be associated with the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the patient incident was not able to confirm a device issue which would have resulted in the adverse event.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
2008T HEMODIALYSIS SYS., WITH CDX
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
CONCORD MANUFACTURING
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
4040 nelson avenue
concord CA 94520
Manufacturer Contact
thomas c. johnson
920 winter st.
waltham, MA 02451
7816999499
MDR Report Key6667977
MDR Text Key78442755
Report Number2937457-2017-00505
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100897
UDI-Public00840861100897
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K093902
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 07/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model Number2008T
Device Catalogue Number190713
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 06/08/2017
Initial Date FDA Received06/26/2017
Supplement Dates Manufacturer Received07/03/2017
Supplement Dates FDA Received07/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/09/2010
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death; Life Threatening; Required Intervention;
Patient Age77 YR
Patient Weight65
-
-